NEW YORK, November 26, 2012 /PRNewswire/ --

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of Epilepsy & Behavior Case Reports a new, online-only, Open Access journal devoted to the rapid publication of case reports on the behavioral aspects of seizures and epilepsy. As a sister journal to Epilepsy & Behavior, case reports published in the new journal will benefit from wide exposure and cross-promotion of the two titles.

Epilepsy & Behavior Case Reports presents original peer-reviewed case reports that feature novel observations, significantly add to previously-reported observations, or provide compelling illustrations of important clinical principles related to the care of patients who have epilepsy and associated behavioral aspects. Topics are drawn from a variety of fields, including clinical neurology, neurosurgery, neuropsychiatry, neuropsychology, neurophysiology, neuropharmacology, and neuroimaging.

Steve Schachter, Professor at the Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, USA and Editor-in-Chief of Epilepsy & Behavior Case Reports said of the launch, "Case reports are the beacons of the scientific frontier, drawing the attention of the scientific community to previously unknown, unobserved, or unaccepted phenomena and thereby influencing the course of scientific progress. This new launch will provide the community with a highly-visible journal in which to publish case reports in this field."

Dieter Schmidt, Emeritus Professor at the Freie Universität Berlin, Berlin, Germany and Associate Editor of the journal, added, "Unexpected observations not only satisfy our curiosity, but may offer clues to better understand the natural history of epilepsy, point out potential new avenues of treatment and teach us to hone our diagnostic acumen."

Articles published in Epilepsy & Behavior Case Reports are freely available to anyone and are published online on ScienceDirect.

For more information or to submit an article, go to Epilepsy & Behavior Case Reports.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Toby Charkin
Elsevier
+44(0)20-7424-4320
t.charkin@elsevier.com